Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab [Phase 4]

View source ↗

Summary

Phase 4 trial exploring how cytokine changes relate to visual outcomes in eyes treated with ranibizumab for macular diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Unity Health Toronto | Conditions: Age Related Macular Degeneration, Diabetic Macular Edema | Phase 4 | Status: UNKNOWN